Pulse Brain · Growing Health Evidence Index
Peer-reviewed

Metadherin is an apoptotic modulator in prostate cancer through miR-342-3p regulation

Kebang Hu, Xupeng Mu, Helena Kolibaba, Qinan Yin, Chune Liu, Xueqing Liang, Lu Ji

Saudi Journal of Biological Sciences · 2018

Read source ↗ All evidence

Summary

Prostate cancer is the second most common cancer in men worldwide. This study focused to clarify the roles of Metadherin (MTDH) and miR-342-3p in prostate cancer. We identified that MTDH was up-regulated and miR-342-3p was down-regulated in the prostate tissues, and there is an inverse correlation between MTDH and miR-342-3p. Functional studies revealed that miR-342-3p directly targets MTDH via binding to the 3' untranslated regions (UTRs) in the prostate cancer cells. Moreover, we also found MTDH overexpression in DU145 and PC3 cells inhibited apoptosis. Subsequently, miR-342-3p has been revealed to reverse the MTDH effect on the cellular apoptosis in the further studies. Our results indicate that MTDH repress apoptosis of prostate cancer in vitro and provides a new strategy for human pro

Source type
Peer-reviewed study
DOI
10.1016/j.sjbs.2018.04.015
Catalogue ID
SNmoi8o93j-mvqbcs
Pulse AI · ask about this record

Dig deeper with Pulse AI.

Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.